Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Administration of Dexmedetomidine Guided by Entropy/SPI Reduce the Requirement of Propofol and Remifentanil as Well as Increase the Quality of Recovery Profile?

NCT02818621 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT02818621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02818621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Administration of Dexmedetomidine Guided by Entropy/SPI Reduce the Requirement of Propofol and Remifentanil as Well as Increase the Quality of Recovery Profile?
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2014
Completion date
October 31, 2017
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia